HOME
About Us
News
Publications
Newsletters
Events
Membership
In-House Training
Members Area
Committee
Discussion Forum
Contact Us
Links
Recruitment
Disclaimer

Changes affecting EU GMP and the FDA's CGMP - Environmental Monitoring in Cleanrooms- One Day Seminar and Table Top Exhibition

EU GMP and the FDA’s CGMP set the target cleanliness levels for pharmaceutical cleanrooms. Both documents refer the reader to ISO 14644 for the methods to determine these cleanliness levels. ISO 14644 is currently under revision. Learn how the inappropriate statistical analysis tools in the current document are to be improved and about the new standard for calibration of air particle counters, ISO 21501-4. Learn about the new ISO 14698 for viable contamination in cleanrooms and it is possible impact on EU GMP Annex 1. Learn about practical solutions to address both the viable and non-viable monitoring challenges for pharmaceutical clean rooms.

Programme

9.00am – 9.30am

Registration, Viewing of Exhibition and Coffee

 

9.30am – 10.30am

Impact on EU-GMP - Tony Harrison – Hach Lange, Vice Chairman - PHSS

• Forthcoming Changes to ISO 14644-1 and 14644-2

• ISO 21501 Calibration of Air Particle Counters

 

10.30am – 11.15am

Proposed Changes to ISO 14698 for Microbial Sections - Tony Harrison – Hach Lange, Vice Chairman - PHSS

• PHSS Technical Monograph No. 2 – Review

 

11.15am – 11.35am

Morning Break incl viewing of Exhibition

 

11.35am – 12.20pm

Bacterial Identification at Genotype Level - Simon McEwen – McEwen Laboratories

 

12.20pm – 13.30pm

Lunch and Viewing of Exhibition

 

13.30pm – 14.30pm

Automation of Viable Monitoring and the concept of integrated viable and non-viable particle monitoring systems - David Hall – PMS

 

14.30pm – 14.45pm

Afternoon Break

 

14.45pm – 15.45pm

Viable Particle Counting - Joyce Johnson – AstraZeneca

 

15.45pm – 16.00pm

Close

Click Here to download full Programme

Venue

AstraZeneca, Charnwood

Speakers

Tony Harrison - Hach Lange, Vice Chairman, PHSS
Simon McEwen - McEwen Laboratories
David Hall - PMS
Joyce Johnson - AstraZeneca

Date

May 13, 2010

Enquiries

Contact the PHSS Office for more details

Costs

Member £ 300.00 + VAT
Non Member £ 400.00 + VAT

Book This Event

Latest News

White Paper Release - Restricted Access Barrier Systems - RABS
Find Out More
Regulatory Update No.99 August 2010
Find Out More
Regulatory Update No.98 July 2010
Find Out More

Events

2010

September

15 Hospital Pharmacy Isolator Training - London
20 Fundamentals of GMP - a Practical Approach
22 Hospital Pharmacy Isolator Training - Bristol